Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany—Results from the SeBluCo Study 2020–2022

SARS-CoV-2 serosurveillance is important to adapt infection control measures and estimate the degree of underreporting. Blood donor samples can be used as a proxy for the healthy adult population. In a repeated cross-sectional study from April 2020 to April 2021, September 2021, and April/May 2022,...

Descripción completa

Detalles Bibliográficos
Autores principales: Offergeld, Ruth, Preußel, Karina, Zeiler, Thomas, Aurich, Konstanze, Baumann-Baretti, Barbara I., Ciesek, Sandra, Corman, Victor M., Dienst, Viktoria, Drosten, Christian, Görg, Siegfried, Greinacher, Andreas, Grossegesse, Marica, Haller, Sebastian, Heuft, Hans-Gert, Hofmann, Natalie, Horn, Peter A., Houareau, Claudia, Gülec, Ilay, Jiménez Klingberg, Carlos Luis, Juhl, David, Lindemann, Monika, Martin, Silke, Neuhauser, Hannelore K., Nitsche, Andreas, Ohme, Julia, Peine, Sven, Sachs, Ulrich J., Schaade, Lars, Schäfer, Richard, Scheiblauer, Heinrich, Schlaud, Martin, Schmidt, Michael, Umhau, Markus, Vollmer, Tanja, Wagner, Franz F., Wieler, Lothar H., Wilking, Hendrik, Ziemann, Malte, Zimmermann, Marlow, der Heiden, Matthias an
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144823/
https://www.ncbi.nlm.nih.gov/pubmed/37111436
http://dx.doi.org/10.3390/pathogens12040551